![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 48, 37454-37461, December 1, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, May 18, 2000, and in revised form, September 5, 2000
The transcription factor Max is the obligate
dimerization partner of the Myc oncoprotein. The pivotal role of Max
within the Myc regulatory network is dependent upon its ability to
dimerize via the helix-loop-helix leucine zipper domain. The Max
homodimer contains a tetrad of polar residues at the interface of the
leucine zipper domain. A conserved interfacial Asn residue at an
equivalent position in two other leucine zipper proteins has been shown
to decrease homodimer stability. The unusual arrangement of this Gln-Asn/Gln'-Asn' tetrad prompted us to investigate whether
Asn92 plays a similar role in destabilizing the Max
homodimer. This residue was sequentially replaced with aliphatic and
charged residues. Thermal denaturation, redox time course and
analytical ultracentrifugation studies show that the N92V mutation does
not increase homodimer stability. Replacing this residue with
negatively charged side chains in N92D and N92E destabilizes the mutant
homodimer. Further replacement of Gln91 indicated that H
bonding between Gln91 and Asn92 residues is not
significant to the stability of the native protein. These data
collectively demonstrate the central role of Asn92 in
homodimer interactions. Molecular modelling studies illustrate the
favorable packing of the native Asn residue at the dimer interface compared with that of the mutant Max peptides.
The human Max protein was identified by Blackwood and Eisenman (1)
as the dimerization partner of the Myc oncoprotein. Heterodimerization
with Max has been shown to be essential for the DNA binding,
transcription activating, transformative, and apoptotic properties of
Myc (2). Max forms homodimers in addition to heterodimers with other
members of the basic helix-loop-helix (HLH)1 leucine zipper (LZ)
family of transcription factors. These include Mxi1 (3); Mad1, Mad3,
and Mad4 (4, 5); and Mnt (6, 7). Max has also been shown to associate
with a member of the DNA-binding domain family of transcription
factors, TFE-1 (8). However, of the proteins involved in this complex
regulatory network, only Max and Mnt form homodimers under
physiological conditions. The role of the Max-associated bHLH LZ
proteins in the regulation of cell growth, differentiation, and
apoptosis depends upon dimerization with Max (9, 10).
The HLH family of proteins is characterized by a domain consisting of
two amphipathic The leucine zipper is a dimerization motif characterized by a heptad
repeat of leucine residues (14, 15). Folded dimers form a parallel,
coiled-coil of The HLH LZ dimer interacts as a parallel, left-handed, four-helix
bundle, with each monomer consisting of two right-handed The majority of LZ proteins contain an a position Asn
residue that confers dimer specificity at the expense of stability and higher order oligomer formation. Mutation of this interfacial polar
residue to a Val residue in the GCN4 LZ dramatically stabilizes the
coiled-coil and promotes the formation of higher order oligomers (23).
NMR studies of a recombinant Jun LZ peptide showed that its interfacial
Asn residue is hydrogen bonded (H bonded) and adopts two distinct,
rapidly exchanging conformations in solution (24). Mutation of this Asn
to a Leu residue caused changes in dimer stability and oligomerization
status comparable with the behavior of the Asn to Val mutant of GCN4.
Max contains two such a position Asn residues,
Asn78 and Asn92. These residues may play a
destabilizing role akin to that of the interfacial Asn in Jun and GCN4.
In addition to the classical hydrophobic interactions at the dimer
interface, the LZ domain of the Max homodimer exhibits unusual
structural features (18, 20). Two regions in particular are unique
among the known LZ proteins: an interfacial His-His' packing at
position 81, and a tetrad between Gln-Asn/Gln'-Asn' at positions 91 and
92 toward the C terminus of the LZ. These residues are likely to be
responsible for the propensity of Max to form a variety of heterodimers
rather than Max-Max homodimers.
Studies using isolated LZ domains (25, 26) have analyzed the role of
these two regions in the context of the Myc-Max heterodimer. These
indicate that a buried salt bridge between His81 of the Max LZ and two
opposing glutamate residues of the Myc LZ resolves the problem of
having these destabilizing hydrophilic residues at the dimer interface.
The proton NMR structure of the Myc-Max LZ heterodimer (27) shows
Asn92 of Max forming an H bond with the backbone carbonyl
of Leu420 of the Myc LZ, thus allowing the burial of the
polar residue within the hydrophobic core of the LZ.
Our study sheds light on the function and importance of
Asn92 in the context of the Max dimerization domain. The
position of this residue at the dimer interface makes it a likely
candidate for one of the destabilizing residues important in
facilitating peptide exchange between members of the bHLH LZ regulatory
network. There is the potential for an array of H bonds to be formed
between the Gln-Asn/Gln'-Asn' tetrad of residues, in contrast to the
relatively simple Asn/Asn' interaction seen previously in the Jun and
GCN4 homodimers. This unusual arrangement makes it an attractive target for mutagenesis studies, with the goal of dissecting the role of
Asn92 in Max HLH LZ homodimerization.
Cloning and Mutagenesis--
A synthetic gene was designed which
encoded the HLH and LZ domains of the human Max protein (amino acids
37-105)2 with an additional
Gly-Gly-Gly at the N terminus and Gly-Gly-Cys at the C terminus.
BamHI sites were incorporated onto the 5' and 3' ends of the
coding sequence to permit insertion into the pGEX-2T expression vector
(28). The final DNA sequence was optimized for bacterial expression by
replacing rare codons with those frequently used in Escherichia
coli (29). pGEXMax+G was isolated by expression screening, and its
identity was confirmed by automated DNA sequencing in both strands.
Mutagenic polymerase chain reaction (30) was used to introduce changes
into pGEXMax+G, yielding the aspartate (pGEXMaxV), glutamate
(pGEXMaxE), and valine (pGEXMaxV) mutant clones used in this study.
Polymerase chain reaction primers were designed to remove the
Gly-Gly-Gly encoding from the 5' region of HLH LZ sequences. Polymerase
chain reaction was also used to create an additional clone encoding the
native Max HLH LZ sequence without the N-terminal Gly-Gly-Gly
(pGEXMaxN). The four mutagenic primers were: 1)
GGATCCGACCACATCAAAGACTCCTTC, 2) CTGAAACGTCAGGA(C/A)GCTCTGCTGGAA, 3)
TTCCAGCAGAGCAACCTGACGTTTCAG, and 4) GGATTCTAATAGTGATCACTATTAGCAAC. Four
additional mutagenic primers were used to make the two Q91A mutant
forms: 5) CAGAGCGTTAGCACGTTTCAG, 6) CTGAAACGTGCTAACGCTCTG, 7)
CAGAGCCACAGCACGTTTCAG, and 8) CTGAAACGTGCTGTGGCTCTG. Expression screening isolated mutant clones and automated DNA sequencing of both
strands confirmed their identities.
Protein Production--
Each GST-Max fusion protein was
overexpressed in E. coli DH5 CD Measurements--
Each homodimer was diluted from stock
solutions into physiological ionic salt buffer (50 mM
Tris·HCl, 125 mM NaCl, 1 mM EDTA, pH 7.4) to
a final peptide concentration of 0.1 mg/ml. Stock peptide concentrations were determined by UV absorbance at 280 nm
(A280) using the extinction coefficient value of
2620 cm Redox Time Course Experiments--
Owing to its additional Gly
residues, Max+G was used in place of MaxN for redox experiments to
facilitate identification of each protein species. Approximately
equimolar amounts of each disulfide-linked HLH LZ homodimer were
incubated in redox buffer containing 50 mM Tris·HCl, 125 mM NaCl, 1 mM EDTA, 250 µM
glutathione (oxidized), 250 µM glutathione (reduced), pH
8.3. Dissolved O2 was removed from the reaction mixture by
10 min of continuous N2 infusion. The reaction mixture was
incubated at 37 °C under N2 in an airtight tube.
100-µl samples were taken at 0, 3, and 16 h, and a 300-µl
sample was taken after 4 days. Samples were analyzed by HPLC on an
analytical Delta Pak C-18 column (Waters, Milford, MA) with a linear
gradient identical to that used for peptide purification. Peaks were
collected and lyophilized, and their identities were confirmed by
ESMS.
The calculated molecular weights for each species are as follows: Max+G
homodimer (17,293), Max+G-glutathione conjugate (8,953), MaxD homodimer
(16,952), MaxD-glutathione conjugate (8,783), MaxE homodimer (16,980),
MaxE-glutathione conjugate (8,797), MaxV homodimer (16,918), and
MaxV-glutathione conjugate (8,766).
Model Building--
Molecular models were created on a Silicon
Graphics workstation using the InsightII suite of programs (version
97.0, Molecular Simulations Inc., 1997). The crystal structure of the
HLH LZ domains of the Max homodimer bound to its cognate DNA fragment
(18) was used as a template. Hydrogen atoms were added to the crystal structure at standard chemical positions. Two residues were replaced; these were Ala residues present in the pdb coordinates but
not present in the originally published human Max sequence (1). The two
Ala residues in each monomer were replaced by His79 and
Gln82. Asn92 was replaced by either Asp, Glu,
or Val residues to create the three mutant model homodimers-MaxD, MaxE,
and MaxV. The bound DNA fragment was removed from the system prior to
energy minimization calculations. Each model was immersed in a 40 × 115 × 40 Å box filled with water molecules. The potential
energy of the molecular system was minimized using the consistent
valence force field (35). Energy minimization of the homodimer models
was performed as a stepwise process designed to gradually release the
molecule from restraints tethering it to Max crystal structure
coordinates (36). Hydrogen atoms were relaxed using Steepest Descents
for 20 iterations; all other atoms were tethered to their original positions. Peptide side chain atoms and oxygen atoms of water molecules
were then released from tethering restraints and energy minimized for a
further 20 iterations using the same algorithm. Restraints were
released from the rest of the molecule for the final energy
minimization of 300 iterations using conjugate gradients. The
stereochemical quality of each model was assessed using the program
Procheck (37).
CD Measurements--
The CD spectra at 10 °C for each of the
peptides is shown in Fig. 1A.
Thermal denaturation of the disulfide bridged homodimers was followed
by measurements of [
MaxN shows a cooperative unfolding event with a melting temperature
(Tm) of 57 °C. Tm is
defined as the temperature at which half the peptide population is
folded. The thermal denaturation profile exhibited good correlation to
the theoretical curve.
MaxE also displayed a thermal denaturation profile in keeping with a
cooperative mechanism of unfolding. However, the exchange of the polar
Asn residue for the more bulky, charged side chain of Glu had a strong
destabilizing effect. At 10 °C, MaxE showed less ellipticity than
MaxN, indicating that the population of MaxE molecules contained less
helical secondary structure. The Tm of MaxE was
37 °C, considerably lower than that of MaxN.
MaxV exhibited an unfolding pattern similar to that of MaxN up to
approximately 85 °C (Fig. 1B). From 85 to 95 °C, MaxV
showed the beginning of a second unfolding transition (Fig.
1C). This second transition was reproducible from peptide
concentrations of 0.005-1.0 mg/ml and throughout the series of 22 separate thermal denaturation experiments performed on MaxV. Although
the helicity of MaxV at 10 °C was not as marked as that of the
native peptide, the Val mutant undergoes its initial denaturation event
at approximately the same temperature, 58 °C compared with 57 °C
for MaxN. The second transition had an approximate
Tm of 90 °C, although this is only an
estimate because the ellipticity values had not plateaued by 95 °C,
which is the upper limit of the CD spectrometer. Additional thermal
denaturation experiments performed with MaxV in physiological ionic
salt plus 4 M urea failed to clarify the characteristics of
this second unfolding event (data not shown).
The second transition displayed by MaxV contrasts significantly with
the profiles exhibited by the other peptides. For this reason, we
wished to exclude the possibility of higher order interactions. The
Tm for the first denaturation transition of MaxV
was concentration independent across the range of samples studied (Fig.
2A). Data from sedimentation
equilibrium measurements carried out on MaxV fitted well to a single
species model where the only species present was the disulfide-bonded
MaxV dimer with an apparent molecular weight of 18300 ± 1700 Da
(Fig. 2B). Fitting the data to a monomer-dimer equilibrium
(disulfide bridged dimer-tetramer) gave a marginally better fit, with a
dimerization constant of 420 M
MaxD was predominantly unfolded for the duration of the thermal
denaturation experiment (Fig. 1B). The unfolding pathway
suggests multiple points of slight inflection, indicating that the
small amount of helical MaxD present melts in a sequential manner
consistent with subdomains unfolding within the HLH LZ. The melting
temperatures of these inflection points were not determined because it
is apparent that MaxD does not display a dimer to monomer unfolding
pattern under these conditions.
To exclude the possibility that the C-terminal disulfide bond was
artificially imparting the correct dimer alignment and thus masking any
role of the Asn residue in orientating the molecules, the thermal
denaturation profiles of MaxN and MaxV were examined under the reducing
conditions imparted by a 5-fold excess of Tris(2-carboxyethyl)phosphine hydrochloride (TCEP). Neither denaturation profile varied
significantly from those of their respective disulfide bridged
homodimers (data not shown).
Two additional mutant proteins were made to assess whether
Gln91 influenced the stability of the native or Val mutant
proteins. These were MaxAN and MaxAV, in which Gln91 was
replaced by Ala in MaxN and MaxV, respectively. Thermal denaturation of
MaxAN and MaxAV was followed by measurements of [ Redox Time Course Experiments--
To determine whether there was
preferential formation of homodimer or heterodimer species between
mutant Max forms and the native Max sequence, dimerization behavior was
studied under redox conditions. By virtue of additional Gly residues at
the N terminus of the native sequence, Max+G was used in place of MaxN
for redox experiments. This facilitated identification of each protein
species. In each case, the native peptide showed a weak propensity to
form mixed disulfides with glutathione from an initially homodimeric state. After 4 days, 5-14% of Max+G was covalently bound to glutathione.
MaxD showed a strong preference to dissociate from an initially
homodimeric form into a mixed disulfide with glutathione (MaxD-SG). The
MaxD-SG form was evident after only 3 h. After 4 days, 46% of the
MaxD peptide was present as a glutathione-bound monomer (Fig.
4). Max+G also formed mixed disulfides
with glutathione, however, to a lesser degree than MaxD; after 4 days,
only 5% of the Max+G peptide was present in this form. Max+G showed no
propensity to interact with MaxD.
MaxE behaved similarly to MaxD. It showed the presence of a small
amount of glutathione adduct after 3 h, and after 4 days this had
increased to 68% of the MaxE peptide (Fig.
5). Max+G again displayed a weak
propensity to dissociate from its homodimeric form and react with
glutathione. After 4 days, 14% of the Max+G peptide was covalently
bound to glutathione. ESMS analysis of the minor peak 4 identified two
contributing species, suggesting a mixture of dimer components.
The MaxV mutant displayed a similar monomer-dimer distribution to that
of the native Max+G protein. After 4 days, 9% of the Max+G peptide and
5% of the MaxV peptide had formed mixed glutathione disulfides (Fig.
6). There was no evidence of interaction
between the Max+G and MaxV peptides.
Molecular Modelling--
Computer models of the native Max
homodimer and the various mutant homodimers were constructed to gain an
understanding of interactions at the dimer interface, particularly
those occurring at the tetrad of Asn-Gln/Asn'-Gln' residues.
The model MaxN homodimer was based on the truncated Max bHLH LZ crystal
structure and shows Gln91 and Asn92 in close
apposition (Fig. 7A). These
residues participate in a tetrad with the Gln91' and
Asn92' side chains of the opposing monomer. The burial of
these four polar residues at the dimer interface is a substantially
different conformation to that of the classical Asn/Asn' H bonding seen in other LZ peptides (1). All four side chains are in positions where
they may form H bonds.
The model of the MaxV homodimer shows the hydrophobic side chain of
each Val residue directed toward its Val' counterpart at the dimer
interface (Fig. 7C). This occurs at the expense of the
burial of the Gln side chains, which, in comparison to their positions
in the native homodimer, are displaced outwards from the dimer
interface. The close apposition of the Val side chains provides a
continuation of the hydrophobic LZ interface.
The Asp side chains of MaxD are positioned close to the amide protons
of the opposing Gln residues (Fig. 7B). However, charge repulsion between the Asp residues on different strands is likely to
counteract the benefits of any attractive forces generated between Asp
and Gln. Presumably, it is this repulsion that results in a cavity at
the dimer interface.
Molecular modelling of the MaxE homodimer reveals Glu side chains
forming intramolecular salt bridges with Lys89 (Fig.
7D). There is no evidence for intermolecular interactions at
this level of the LZ; indeed there is considerable space between the
monomers, presumably caused by repulsion between the negatively charged
Glu side chains.
Previous studies on interfacial Asn residues have indicated that
they play an important role in homodimer destabilization, facilitating
zipper exchange, and promoting heterodimer formation. The novel nature
of the Asn-Gln/Asn'-Gln' tetrad affords an opportunity to extend our
knowledge of the role of these polar residues.
CD spectra analysis revealed MaxN to be the most helical of the
peptides studied. The estimation of 91% As expected, the presence of a charged residue at the dimer interface
proved to be unfavorable for homodimer formation and stability. Data
obtained by thermal denaturation and redox time course studies revealed
that both MaxD and MaxE were less stable as homodimers than was native Max.
Thermal denaturation and redox time course studies show that disrupting
the polar tetrad by substitution of Asn92 with a Val
residue did not increase the stability of the MaxV homodimer over that
of the native MaxN peptide (Figs. 1B and 6). The MaxV
homodimer was estimated to be 15% less helical than MaxN at 10 °C
(Fig. 1A). This is in contrast to the effect of similar hydrophobic substitutions in other LZ peptides, which were shown to
dramatically increase the stability of the mutant homodimers. The
corresponding Asn to Leu mutant of Jun undergoes a thermal denaturation
transition corresponding to a dimer to monomer unfolding event at
75 °C, in comparison with 52 °C for the native peptide (24). GCN4
increased its Tm from 53 to 95 °C upon
incorporating a Val residue in place of the naturally occurring
a position Asn (23). In contrast, MaxV and MaxN undergo
unfolding transitions at 58 and 57 °C, respectively. Both peptides
also displayed a similar tendency to remain as homodimers under redox conditions.
The possibility that the 58 °C transition event of MaxV represented
an oligomer to dimer unfolding event, thus pointing to the second
denaturation (at >90 °C) as the true dimer to monomer melting
temperature, was excluded by varying the peptide concentration of MaxV
during thermal denaturation studies. Both unfolding events were shown
to be concentration-independent (Fig. 2A) and hence represent partial unfolding of the disulfide bridged dimer rather than
the melting of associating MaxV dimers. Sedimentation equilibrium studies support this conclusion (Fig. 2B), indicating that
less than 1% of the total protein present could be in a tetrameric form at 0.1 mg/ml. Because each MaxV dimer has two contiguous domains
containing four MaxD and MaxE displayed considerably less secondary structure at
10 °C than either MaxV or MaxN (Fig. 1A), as well as
being considerably less stable as dimers in the redox time course
assay (Figs. 4 and 5). Thus, it is unlikely that the unfolding data reflect a cooperative unfolding of dimer and tetramer species in the
two charged mutants. Sedimentation equilibrium studies supported these
results by confirming that both MaxD and MaxE were predominantly
(>90%) disulfide bridged dimers under the conditions of this study
(data not shown).
The close proximity of the polar side chains of Gln91 to
the Val residues of MaxV may have had a negative influence on any
stabilizing effects of this mutation, thus masking the true effect of
the N92V substitution. Thermal denaturation studies of MaxAV showed that this was not the case (Fig. 3). We conclude that replacement of
Asn92 with a Val residue does not increase the stability of
the native protein.
Because the crystal structures of Max were determined at 2.8 and 2.9 Å, it is not possible to identify the H bonding patterns of the amide
tetrad residues. Additionally, in the full-length structure the LZ is
disordered beyond Asn92; hence the exact positions of the
tetrad side chains cannot confidently be assigned. Inspection of the
MaxN model structure revealed the possibility for multiple, albeit
nonideal, H bonding arrangements at the level of the Asn-Gln/Asn'-Gln'
tetrad (Fig. 7A). However, the similar
Tm values of MaxAN and MaxN (Fig. 3A)
showed that H bonding between Gln and Asn residues does not contribute
significantly to the stability of the native protein.
We propose a model of interaction where the relative stability of MaxN
may be accounted for by H bonds formed across the dimer interface
between the symmetrically oriented Asn side chains, because
these residues are positioned differently to the equivalent asymmetrical polar elements of GCN4 and Jun. It is unlikely that Asn92 is involved in a conformational exchange process
comparable with that of the interfacial Asn residues in the Jun LZ
(24), because the truncated Max crystal structure indicates that both
Asn residues are in a symmetrical conformation. Additionally, motional
averaging by these Asn residues would necessitate the displacement of
the Gln side chains from their positions at the dimer interface. Hence, where GCN4 and Jun are destabilized by the movement of asymmetrical Asn
residues, Max is not destabilized, possibly because Asn92
is able to form permanent H bonds between symmetrical side chains.
Remarkably, the presence of four polar residues at the dimer interface
is not destabilizing to the MaxN homodimer. The extent of unfavorable
desolvation of the polar Asn residues at the hydrophobic dimer
interface is, therefore, not as substantial as occurs in the LZs of Jun
and GCN4. We propose that H bonds between the Asn side chains
compensate for the presence of these buried polar entities.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1AN2) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence should be addressed. E-mail:
aweiss@mail.usyd.edu.au.
Published, JBC Papers in Press, September 7, 2000, DOI 10.1074/jbc.M004264200
2
The amino acid sequence of this protein
corresponds to Swiss-Prot number P25912 (1).
3
B. P. Surin and N. E. Dixon,
unpublished results.
The abbreviations used are:
HLH, helix-loop-helix;
bHLH, basic HLH;
LZ, leucine zipper;
GST, glutathione
S-transferase;
HPLC, high pressure liquid chromatography;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine;
ESMS, electrospray mass spectrometry.
Interfacial Asparagine Residues within an Amide Tetrad Contribute
to Max Helix-Loop-Helix Leucine Zipper Homodimer Stability*
,
,
,
,
¶
Department of Biochemistry, University of
Sydney, Sydney, New South Wales 2006, Australia and the
§ Department of Biochemistry, University of Connecticut
Health Center, Farmington, Connecticut 06030
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helices joined by a short, nonconserved loop of
random coil. HLH dimers form a globular fold of four interacting
-helices (11, 12) in which stability and specificity are mediated
through highly conserved hydrophobic residues at the core of the HLH
domain (13).
-helices in which, by conventional nomenclature,
(abcdefg)n, the heptad repeat Leu residues occupy
position d at the dimer interface. Leu is highly conserved at this position throughout the LZ family of proteins, presumably because its side chain size and structure is such that it provides optimal hydrophobic packing. Another heptad repeat of hydrophobic residues, typically the
-branched amino acids such as Ile and Val,
are found in position a at the dimer interface. There is debate over the role of interhelical salt bridges between charged residues in positions e and g in the coiled-coil.
Unfavorable e-g' electrostatic interactions, where an
apostrophe indicates a residue from the apposing chain in the
dimer, have been shown to inhibit dimer formation (16) and potentially
promote strand exchange. However, the presence of attractive
e-g' ion pairs may not contribute significantly to dimer
stability; indeed, they may be less stabilizing than an equivalent
neutral charge interaction (17).
-helices
joined by the loop region of the HLH domain. The LZ extends as a
coiled-coil out of the globular fold formed by the HLH domain. Crystal
structures of two HLH LZ proteins, USF and Max, show that the
dimerization domain is a single, contiguous functional element, with
helix-2 of the HLH extending into the LZ such that there is no clear
demarcation between the two domains (18-20). Horiuchi et
al. (21) have shown that the Max bHLH-Z domain homodimerizes
cooperatively in a manner consistent with a two-state monomer to dimer
association. There is also evidence that the Max HLH LZ is able to
interact as a tetramer under certain conditions (20, 22).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
that also contained
pBS536. pBS536 contains the 2.2-kb GroE+ EcoRI-HindIII fragment of pOF39 (MGG 202, 435-445) inserted at the EcoRV site within the
tet gene of pACYC184 in an orientation that does not permit
its expression from the tet
promoter.3
Coexpression of GroEL and GroES from pBS536 increased the amount of
soluble GST-Max proteins produced to approximately 50% of total expressed fusion protein (data not shown). Cells were induced with 0.5 mM isopropyl-1-thio-
-D-galactopyranoside and
grown at 37 °C for 3 h prior to harvesting. GST-Max fusion
proteins were separated from cellular proteins by glutathione-agarose
affinity chromatography, and Max proteins were released from the fusion protein at the engineered thrombin site with bovine thrombin. Max
proteins were purified by HPLC on a semi-preparative Vydac C-18 column
with a linear gradient from 25 to 45% acetonitrile 1% (v/v)
trifluoroacetic acid, over 30 min. Following HPLC, the protein
preparations used in this study were confirmed to be pure by Tricine
gel electrophoresis and of the correct molecular weight by ESMS
(Australian Government Analytical Laboratories).
1 M
1 for each Max
peptide. Far ultraviolet CD spectra from 200 to 260 nm were collected
on a Jasco J-720 spectropolarimeter flushed continuously with
N2 and routinely calibrated with
D-(+)-camphor-10-sulfonic acid. For thermal denaturation
profiles, ellipticity at 222 nm for each of the disulfide bridged
homodimers was measured over a linear temperature gradient from 10 to
95 °C at 1 °C/min. Additional thermal denaturation data were
collected for MaxV over a number of peptide concentrations: 1.0, 0.05, 0.01, and 0.005 mg/ml. Base-line spectra of physiological ionic salt
buffer were collected and subtracted from all data prior to conversion
into mean residue weight ellipticity values using the following formula.
where mean residue weight ellipticity ([
(Eq. 1)
]) is expressed in
deg·cm
2·dmol
1,
is raw ellipticity
values, MRW is the molecular weight divided by the number of
residues in the peptide, c is the peptide concentration in
mg/ml, and d is the pathlength in centimetres through the
optical cell (26). Estimates of
-helical content were generated by the K2D program (31, 32). The thermal denaturation profile was fitted
to either sigmoidal function (i) for MaxN and MaxE or (ii) in the case
of MaxV. The thermal denaturation profile of MaxD was not subjected to
model fitting.
(Eq. 2)
Analytical Ultracentrifugation
(Eq. 3)
The self-association of each Max
protein was investigated by sedimentation equilibrium methods on a
Beckman XL-A analytical ultracentrifuge. Experiments were carried out
at loading concentrations of 150, 125, 41.5, and 13.2 µM,
using an An-60ti rotor spinning at 20,000, and 25,000 rpm and at a
temperature of 25 °C. Samples were made up as solutions in
physiological ionic salt buffer. Sedimentation equilibrium data were
collected in double sector cells as absorbance versus radius
scans (0.001-cm increments, 10 scans). Scans were collected at 4-h
intervals and compared with determine when the samples had reached
equilibrium. Analysis of the data was carried out using the NONLIN
software (33), and the final parameters were determined by simultaneous
nonlinear least squares fits of all data sets to either a single
species (disulfide-bonded dimer) or a dimer-tetramer model. The
goodness of fit was determined by examination of the residuals from the
fits and consideration of the
2 values. Partial specific
volumes were calculated from the amino acid sequence, and the solvent
density was calculated to be 1.00482 g ml
1; both
calculations were carried out using the program SEDNTERP (34).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Helicity estimates were 91% for the native protein (MaxN); and 20, 21, and 76% for the mutant proteins, N92
D (MaxD), N92
E (MaxE),
and N92
V (MaxV), respectively.

View larger version (19K):
[in a new window]
Fig. 1.
Far ultraviolet circular dichroism analysis
of Max peptides. A, CD spectra of MaxN (
), MaxD
(
), MaxE (×), and MaxV (
) from 200 to 260 nm.
B, thermal denaturation curves of MaxN (
), MaxD (
),
MaxE (×), and MaxV (
) were followed by circular
dichroism spectroscopy at 222 nm. Decreasing absolute values of
[
]222 caused by heating correlate with a loss of
secondary structure in each disulfide bridged peptide. C,
thermal denaturation curves of MaxN (
) and MaxV (
) from 65 to
95 °C. The
[
]222/
temperature of MaxV
increased over this range, whereas that of MaxN decreased, indicating a
second unfolding event for MaxV.
]222 from 10 to 95 °C (Fig.
1B). Decreases in absolute [
]222 correlate
with decreasing
-helicity and the formation of monomeric peptides
from the initial homodimers. Each protein underwent a decrease in
helicity and a shift to an increasingly random structure as it was
heated. However, the initial helicities and unfolding pathways differed
for each of the peptides studied.
1. However,
under these conditions the protein would be >99% dimeric at 0.1 mg/ml. We propose that both models fitted the data similarly because
although the propensity of MaxV to form higher order aggregates appears
to be real, under our experimental conditions it is small enough that a
single species dimeric model describes the interaction adequately.
Taken together, these results indicate that MaxV is present
predominantly as a disulfide bridged dimer under the conditions of this
study.

View larger version (22K):
[in a new window]
Fig. 2.
Thermal denaturation curves at varying
concentrations and analytical ultracentrifugation studies of MaxV.
A, thermal denaturation curves of MaxV at 1.0 mg/ml (
),
0.1 mg/ml (
), 0.05 mg/ml (×), 0.01 mg/ml (
), and
0.005 mg/ml (
). B, sedimentation equilibrium data for
MaxV at 20,000 (
), and 25,000 (
), recorded at a loading
concentration of 150 µM and at 25 °C. Residual plots
are also shown for each data set, demonstrating the goodness of fit to
both ideal single species (disulfide bridged dimer at 20,000 (
) and
25,000 (
)) and ideal monomer-dimer (disulfide bridged dimer to
tetramer at 20,000 (
) and 25,000 (
)) models. The fit to the
dimer-tetramer model is marginally better, judging from sums of
squares.
]222
from 10 to 95 °C (Fig. 3). Both
molecules showed unfolding profiles similar to those of MaxN and MaxV.
MaxAN had a Tm of 57 °C, which compared
closely to that of MaxN (58 °C). MaxAV similarly unfolded at a
comparable temperature to that of MaxV (57 and 58 °C, respectively).

View larger version (16K):
[in a new window]
Fig. 3.
A, thermal denaturation curves of MaxV
(
) and MaxAV (*). Tm values were 58 and
57 °C for MaxV and MaxAV, respectively. B, thermal
denaturation curves of MaxN (
) and MaxAN (
).
Tm values were 57 and 58 °C for MaxN and
MaxAN, respectively.

View larger version (14K):
[in a new window]
Fig. 4.
Redox equilibrium experiment containing Max+G
and MaxD peptides. HPLC chromatograms are shown from samples taken
at 0 h (A), 3 h (B), 16 h
(C), and 4 days (D). The molecular weights
obtained from each peak by ESMS are indicated in D. In each
case the vertical axis represents increasing absorbance at
215 nm.

View larger version (15K):
[in a new window]
Fig. 5.
Redox equilibrium experiment containing Max+G
and MaxE peptides. HPLC chromatograms are shown from samples taken
at 0 h (A), 3 h (B), 16 h
(C), and 4 days (D). The molecular weights
obtained from each peak by ESMS are indicated in panel D. In each case
the vertical axis represents increasing absorbance at 215 nm.

View larger version (15K):
[in a new window]
Fig. 6.
Redox equilibrium experiment containing Max+G
and MaxV peptides. HPLC chromatograms are shown from samples taken
at 0 h (A), 3 h (B), 16 h
(C), and 4 days (D). The molecular weights
obtained from each peak by ESMS are indicated in panel D. In each case
the vertical axis represents increasing absorbance at 215 nm.

View larger version (76K):
[in a new window]
Fig. 7.
Molecular models of the various Max
homodimers at the level of the
Gln91-Asn92/Gln91'-Asn92'
tetrad. A, MaxN; B, MaxD; C,
MaxV; D, MaxE. Each homodimer is displayed such that the
atoms on the left-hand side of each panel are from one
monomer, and those on the right-hand side are from the
other. Gln residues are shaded dark gray. Asn, Val, Asp, and
Glu residues are shaded light gray in each model,
respectively. Lys89 is displayed as light gray rendering in
the MaxE homodimer model.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helicity for MaxN at
10 °C indicates that approximately 66 of 74 possible residues are in
an
-helical conformation. This correlates with the work of Horiuchi
et al. (21), who reported that 65 residues of a 109-amino
acid dimer containing the bHLH-Z domains of Max were in a helical
conformation. That 8 amino acids are not
-helical also agrees with
the crystal structure of Max that shows a loop length of 8 residues
(18). These values are only estimations of secondary structure, and,
because of the K2D library of proteins being predominantly globular
(31, 32), errors in calculating the secondary structure content of an
elongated domain such as the leucine zipper are possible.
-helices, it is likely that the entire molecule does
not unfold cooperatively in a simple two-state manner. The data
indicate a stepwise model, with the majority of the protein melting at
58 °C and a residual region unfolding at around 90 °C.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Blackwood, E. M.,
and Eisenman, R. N.
(1991)
Science
251,
1211-1217
2.
Amati, B.,
Brooks, M. W.,
Levy, N.,
Littlewood, T. D.,
Evan, G. I.,
and Land, H.
(1993)
Cell
72,
233-245
3.
Zervos, A. S.,
Gyuris, J.,
and Brent, R.
(1994)
Cell
72,
223-232
4.
Ayer, D. E.,
Kretzner, L.,
and Eisenman, R. N.
(1993)
Cell
72,
211-222
5.
Hurlin, P. J.,
Queva, C.,
Koskinen, P. J.,
Steingrimsson, E.,
Ayer, D. E.,
Copeland, N. G.,
Jenkins, N. A.,
and Eisenman, R. N.
(1995)
EMBO J.
14,
5646-5659
6.
Meroni, G.,
Reymond, A.,
Alcalay, M.,
Borsani, G.,
Tanigami, A.,
Tonlorenzi, R.,
Nigro, C. L.,
Messali, S.,
Zollo, M.,
Ledbetter, D. H.,
Brent, R.,
Ballabio, A.,
and Carrozzo, R.
(1997)
EMBO J.
16,
2892-2906
7.
Hurlin, P. J.,
Queva, C.,
and Eisenman, R. N.
(1997)
Curr. Top. Microbiol. Immunol.
224,
115-121
8.
Gupta, M. P.,
Amin, C. S.,
Gupta, M.,
Hay, N.,
and Zak, R.
(1997)
Mol. Cell Biol.
17,
3924-3936
9.
Bouchard, C.,
Staller, P.,
and Eilers, M.
(1998)
Trends Cell Biol.
8,
202-206
10.
Facchini, L. M.,
and Penn, L. Z.
(1998)
FASEB J.
12,
633-651
11.
Wendt, H.,
Thomas, R. M.,
and Ellenberger, T.
(1998)
J. Biol. Chem.
273,
5735-5743
12.
Fairman, R.,
Beran-Steed, R. K.,
and Handel, T. M.
(1997)
Protein Sci.
6,
175-184
13.
Littlewood, T. D.,
Hancock, D. C.,
Danielian, P. S.,
Parker, M. G.,
and Evan, G. I.
(1995)
Nucleic Acids Res.
23,
1686-1690
14.
Landschulz, W. H.,
Johnson, P. F.,
and McKnight, S. L.
(1988)
Science
240,
1759-1764
15.
Alber, T.
(1992)
Curr. Opin. Gen. Dev.
2,
205-210
16.
O'Shea, E. K.,
Klemm, J. D.,
Kim, P. S.,
and Alber, T.
(1991)
Science
254,
539-544
17.
Lumb, K. J.,
and Kim, P. S.
(1995)
Biochemistry
34,
8642-8648
18.
Ferre-D'Amare, A. R.,
Prendergast, G. C.,
Ziff, E. B.,
and Burley, S. K.
(1993)
Nature
363,
38-45
19.
Ferre-D'Amare, A. R.,
Pognonec, P.,
Roeder, R. G.,
and Burley, S. K.
(1994)
EMBO J.
13,
180-189
20.
Brownlie, P.,
Ceska, T.,
Lamers, M.,
Romier, C.,
Stier, G.,
Teo, H.,
and Suck, D.
(1997)
Structure
5,
509-520
21.
Horiuchi, M.,
Kurihara, Y.,
Katahira, M.,
Maeda, T.,
Saito, T.,
and Uesugi, S.
(1997)
J. Biochem. (Tokyo)
122,
711-716
22.
Ferre-D'Amare, A. R.,
and Burley, S. K.
(1994)
Structure
2,
357-359
23.
Harbury, P. B.,
Zhang, T.,
Kim, P. S.,
and Alber, T.
(1993)
Science
262,
1401-1407
24.
Junius, F. K.,
Mackay, J. P.,
Bubb, W. A.,
Jensen, S. A.,
Weiss, A. S.,
and King, G. F.
(1995)
Biochemistry
34,
6164-6174
25.
Muhle-Goll, C.,
Nilges, M.,
and Pastore, A.
(1995)
Biochemistry
34,
13554-13564
26.
Lavigne, P.,
Kondejewski, L. H.,
Houston, M. E. J.,
Sonnichsen, F. D.,
Lix, B.,
Skyes, B. D.,
Hodges, R. S.,
and Kay, C. M.
(1995)
J. Mol. Biol.
254,
505-520
27.
Lavigne, P.,
Crump, M. P.,
Gagne, S. M.,
Hodges, R. S.,
Kay, C. M.,
and Sykes, B. D.
(1998)
J. Mol. Biol.
281,
165-181
28.
Smith, D. B.,
and Johnson, K. S.
(1988)
Gene (Amst.)
67,
31-40
29.
Martin, S. L.,
Vrhovski, B.,
and Weiss, A. S.
(1995)
Gene (Amst.)
154,
159-166
30.
Cadwell, R. C.,
and Joyce, G. F.
(1994)
Genome Res.
3,
S136-S140
31.
Merelo, J. J.,
Andrade, M. A.,
Prieto, A.,
and Morán, F.
(1994)
Neurocomputing
6,
443-454
32.
Andrade, M. A.,
Chacon, P.,
Merelo, J. J.,
and Morán, F.
(1993)
Protein Eng.
6,
383-390
33.
Johnson, M. L.,
Correia, J. J.,
Yphantis, D. A.,
and Halvorson, H. R.
(1981)
Biophys. J.
36,
575-588
34.
Hayes, D. B.,
Laue, T.,
and Philo, J.
(1995)
SEDNTERP
, University of New Hampshire, Durham, NH
35.
Dauber-Osguthorpe, P.,
Roberts, V. A.,
Osguthorpe, D. J.,
Wolff, J.,
Genest, M.,
and Hagler, A. T.
(1988)
Proteins
4,
31-47
36.
Biosym Technologies.
(1993)
InsightII User Guide, Version 2.3.0
, Biosym Technologies, San Diego, CA
37.
Laskowski, R. A.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Mol. Biol.
231,
1049-1067
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M.-K. Yoon, H.-M. Kim, G. Choi, J.-O. Lee, and B.-S. Choi Structural Basis for the Conformational Integrity of the Arabidopsis thaliana HY5 Leucine Zipper Homodimer J. Biol. Chem., April 27, 2007; 282(17): 12989 - 13002. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Marco, M. Massetti, S. Bruscoli, A. Macchiarulo, R. D. Virgilio, E. Velardi, V. Donato, G. Migliorati, and C. Riccardi Glucocorticoid-induced leucine zipper (GILZ)/NF-{kappa}B interaction: role of GILZ homo-dimerization and C-terminal domain Nucleic Acids Res., January 28, 2007; 35(2): 517 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Grinberg, C.-D. Hu, and T. K. Kerppola Visualization of Myc/Max/Mad Family Dimers and the Competition for Dimerization in Living Cells Mol. Cell. Biol., May 15, 2004; 24(10): 4294 - 4308. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mozo-Villarias, J. Cedano, and E. Querol A simple electrostatic criterion for predicting the thermal stability of proteins Protein Eng. Des. Sel., April 1, 2003; 16(4): 279 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ciarapica, J. Rosati, G. Cesareni, and S. Nasi Molecular Recognition in Helix-Loop-Helix and Helix-Loop-Helix-Leucine Zipper Domains. DESIGN OF REPERTOIRES AND SELECTION OF HIGH AFFINITY LIGANDS FOR NATURAL PROTEINS J. Biol. Chem., March 28, 2003; 278(14): 12182 - 12190. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Boysen, A. J. O. Jong, J. A. Wilce, G. F. King, and M. T. W. Hearn Role of Interfacial Hydrophobic Residues in the Stabilization of the Leucine Zipper Structures of the Transcription Factors c-Fos and c-Jun J. Biol. Chem., January 4, 2002; 277(1): 23 - 31. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||